Cyclo Therapeutics Inc (CYTH)

Nov 15, 2024

TeleChoice International’s Path to Exiting SGX Watch-list - MSN

Nov 15, 2024

Nov 15, 2024

Cyclo Therapeutics Inc (CYTH) Quarterly 10-Q Report - Quartz

Nov 15, 2024

Nov 14, 2024

Cyclo Therapeutics Completes Phase 3 Trial Enrollment, Plans 2025 NDA Filing Amid Merger | CYTH Stock News - StockTitan

Nov 14, 2024

Nov 14, 2024

Cyclo Therapeutics, Inc. (CYTH) Reports Q3 Loss, Lags Revenue Estimates - Yahoo Finance

Nov 14, 2024

Nov 14, 2024

Well Health Stock: Buy, Sell, or Hold? - MSN

Nov 14, 2024

Nov 13, 2024

Canopy Growth (CGC) Stock Dives Amid Financial Struggles and Ind - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

AMGN Stock Drops 5% Amid Industry Decline and Earnings Report - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

Siga Technologies (SIGA) Sees Significant Stock Decline Amidst P - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

Niemann-Pick Disease Type C Pipeline 2024: Clinical Trials - openPR

Nov 12, 2024

Nov 10, 2024

Astrazeneca: How a fraud investigation crashed a FTSE 100 giant - MSN

Nov 10, 2024

Nov 07, 2024

Rafael Holdings Inc. Class B (RFL) Annual 10-K Report - Quartzy

Nov 07, 2024

Nov 07, 2024

Analysts Set Cognition Therapeutics, Inc. (NASDAQ:CGTX) PT at $8.00 - Defense World

Nov 07, 2024

Nov 06, 2024

Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results - ForexTV.com

Nov 06, 2024

Nov 06, 2024

Rafael Holdings Reports $34.4M Loss, Inks Merger Deal with Cyclo Therapeutics | RFL Stock News - StockTitan

Nov 06, 2024

Nov 06, 2024

Sofi Technologies Inc (SOFI-Q) QuotePress Release - The Globe and Mail

Nov 06, 2024

Nov 06, 2024

Pacira BioSciences Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 06, 2024

Nov 03, 2024

TSX 60 Index (TXSX) QuotePress Release - The Globe and Mail

Nov 03, 2024

Nov 03, 2024

Pilgrim's Pride (PPC-Q) QuotePress Release - The Globe and Mail

Nov 03, 2024

Oct 25, 2024

Kuehn Law Encourages CDE, SMC, COFS, and RFL Investors to Contac - GuruFocus.com

Oct 25, 2024

Oct 24, 2024

Rare Disease Spotlight: Niemann-Pick pipeline behind two approvals - BioCentury

Oct 24, 2024

Oct 24, 2024

Sonoma Pharmaceuticals (SNOA) Surges Amid Positive Analyst Ratin - GuruFocus.com

Oct 24, 2024

Oct 23, 2024

Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail

Oct 23, 2024

Oct 22, 2024

What Q3 investment banking trends reveal about the economy - Fortune

Oct 22, 2024

Oct 21, 2024

Will Cyclo Therapeutics Get A Boost From NPC-1 Trial Data? - RTTNews

Oct 21, 2024

Oct 21, 2024

Pacira BioSciences Appoints Shawn Cross As Chief Financial Officer - citybiz

Oct 21, 2024

Oct 21, 2024

Pacira BioSciences Appoints Shawn Cross as Chief Financial Officer - The Manila Times

Oct 21, 2024

Oct 18, 2024

Niemann Pick Disease Drug Type C Treatment Market Industry - openPR

Oct 18, 2024

Oct 16, 2024

Deal Watch: Lilly Turns To Oblique For Antibody Discovery - Scrip

Oct 16, 2024

Oct 16, 2024

Nvidia Corp (NVDA-Q) QuotePress Release - The Globe and Mail

Oct 16, 2024

Oct 11, 2024

Alkermes (ALKS) Stock Surges Amid Strong Financial Results - GuruFocus.com

Oct 11, 2024

Oct 11, 2024

Maxim Group Downgrades Cyclo Therapeutics (CYTH) - MSN

Oct 11, 2024

Oct 09, 2024

Cyclo Therapeutics faces Nasdaq delisting over non-compliance - Investing.com

Oct 09, 2024

Oct 09, 2024

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Position Increased by Handelsbanken Fonder AB - Defense World

Oct 09, 2024

Oct 09, 2024

Cyclo Therapeutics faces Nasdaq delisting over non-compliance By Investing.com - Investing.com UK

Oct 09, 2024

Oct 08, 2024

Cyclo Therapeutics secures $3 million in funding from Rafael Holdings By Investing.com - Investing.com South Africa

Oct 08, 2024

Oct 08, 2024

Cyclo Therapeutics secures $3 million in funding from Rafael Holdings - Investing.com India

Oct 08, 2024

Oct 08, 2024

Kuehn Law Encourages CDE, SMC, COFS, and RFL Investors to Contact Law Firm - The Malaysian Reserve

Oct 08, 2024

Oct 07, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDE, SMC, COFS, RFL on Behalf of Shareholders - GlobeNewswire

Oct 07, 2024

Oct 04, 2024

SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Mergers of RFL, PORT and MNTX - AccessWire

Oct 04, 2024

Oct 04, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FYBR, COFS, RFL on Behalf of Shareholders - Lelezard.com

Oct 04, 2024

Oct 02, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MNTX and RFL on Behalf of Shareholders - AccessWire

Oct 02, 2024

Oct 01, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SMAR, MNTX, RFL on Behalf of Shareholders - The Malaysian Reserve

Oct 01, 2024

Sep 28, 2024

Apple Inc (AAPL-Q) QuotePress Release - The Globe and Mail

Sep 28, 2024

Sep 27, 2024

Kuehn Law Encourages RVNC, RFL, BTTR, and ARC Investors to Contact Law Firm - The Malaysian Reserve

Sep 27, 2024

Sep 26, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RVNC, GATO, RFL on Behalf of Shareholders - The Malaysian Reserve

Sep 26, 2024

Sep 25, 2024

Take your (Niemann-) Pick: Intrabio’s Aqneursa wins FDA nod - BioWorld Online

Sep 25, 2024

Sep 24, 2024

Analyzing SOPHiA GENETICS (NASDAQ:SOPH) & Cyclo Therapeutics (NASDAQ:CYTH) - Defense World

Sep 24, 2024

Sep 23, 2024

Cyclo-oxygenase 2 Inhibitors Clinical Trial Pipeline - GlobeNewswire

Sep 23, 2024

Sep 23, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COFS, ARC, NBY, RFL on Behalf of Shareholders - GlobeNewswire

Sep 23, 2024

Sep 23, 2024

Kuehn Law Encourages COFS, ARC, RFL, and NBY Investors to Contact Law Firm - The Malaysian Reserve

Sep 23, 2024